Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Has Article 50 Stymied UK’s Role In Unified Patent Court?

Executive Summary

Those involved in the creation of Europe’s future Unified Patent Court continue to hope that it will open its doors on schedule in December this year, but more doubts are emerging as to whether the UK will be able to play its role in the court system after it leaves the EU.

You may also be interested in...



Germany Heads For Ratification Of Unified Patent Court; Spanish MPs Push For Membership

Germany, one of three countries whose signature is vital if the new Unified Patent Court is to get up and running, has taken another step towards ratification of the UPC agreement, while the Spanish parliament has approved a motion urging the government to drop its opposition to Spain’s becoming part of the new system.

UK To Ratify Unified Patent Court Deal Despite Uncertainty Over Its Future Participation

The UK government has announced that it will proceed with preparations for ratifying Europe’s Unified Patent Court agreement, despite uncertainty over whether the UK will be able to remain part of the UPC system once it leaves the EU.

UK Explains New Rules On Parallel Imports From EU

Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS120431

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel